C Berkeley Inducts CooperVision Research Fellow Dr. Arthur Bradley into Optometry Hall of Fame
Honor Recognizes Contributions to Scientific Advances in Myopia Control and Management
The Herbert Wertheim School of Optometry & Vision Science at the University of California, Berkeley, has inducted Arthur Bradley, Ph.D., CooperVision Research Fellow, into its Hall of Fame. Dr. Bradley joins an elite group of 20 other UC Berkley alumni and faculty who received the honor by making significant and exceptional contributions to the optometry field.
Dr. Bradley earned his Ph.D. in Vision Science/Physiological Optics from UC Berkley in 1983, then embarked on a career at Indiana University as a vision science professor and researcher. Throughout his tenure, he provided mentorship, guidance, and instruction to thousands of Ph.D., optometry, and undergraduate students in fields including optics, visual neuroscience, binocular vision, and visual function.
Since becoming a Research Fellow at CooperVision in 2019, Dr. Bradley and the Research and Development myopia team have gained global recognition for their groundbreaking research on optical interventions aimed at understanding the myopia epidemic. Through his research and publications, particularly in relation to MiSight® 1 day contact lenses, he has helped advance the field of myopia control and management. His work continues to gain widespread recognition, and it is regularly featured at prestigious international conferences.
For detailed profiles and notable accomplishments of all 2023 inductees, visit Berkeley’s Optometry Hall of Fame website at optometry.berkeley.edu/alumni/
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies (“Cooper”) is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com
Laura DiCaprio, Senior Counselor
McDougall Communications for CooperVision
Laura@mcdougallpr.com or +1-585-773-8005